Epidemiology of Stone Disease - 15/08/11
Doi : 10.1016/j.ucl.2007.04.003
Gary C. Curhan, MD, ScD a, b, ⁎ 
a Channing Laboratory and Renal Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
b Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
Channing Laboratory and Renal Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115.Abstract |
Epidemiology has improved our understanding and management of stone disease. Epidemiologic studies, by quantifying patterns and burden of disease, have helped identify risk factors, leading to changes in clinical practice and providing insights into pathophysiologic processes related to stone formation. Because nephrolithiasis is a complex disease, an understanding of the epidemiology, particularly the interactions among different factors, may help lead to approaches that reduce the risk of stone formation.
Le texte complet de cet article est disponible en PDF.Plan
| This work was supported by grant DK59583 from the National Institutes of Health. |
© 2007
Elsevier Inc. Tous droits réservés.
Vol 34 - N° 3
P. 287-293 - août 2007 Retour au numéro
Article précédent
- Preface
- Margaret S. Pearle
- Pathogenesis of Renal Calculi
- Nicole L. Miller, Andrew P. Evan, James E. Lingeman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?